Dashboard › CL1: Health › Key Facts
HORIZON-HLTH-2025-03-STAYHLTH-01-two-stage

Improving the quality of life of persons with intellectual disabilities and their families

RIA Cluster 1 €40,000,000 16 Apr 2026
Topic Code HORIZON-HLTH-2025-03-STAYHLTH-01-two-stage F&T Portal
Call Identifier HORIZON-HLTH-2025-03 Two stage (2025) — Stage 2
Instrument HORIZON-RIA Research and Innovation Action
Budget Model Lump Sum HORIZON-AG-LS
Funding Rate 100% Annex G — RIA = 100%
Page Limit (Part B) 45 pages RIA + lump sum — Stage 2
Evaluation Thresholds 4 / 4 / 4 · cum. 12 Non-standard — Stage 2 override
Expected Projects 5 €6–8M per project (WP stated)
Destination Staying healthy in a rapidly changing society WP Part 4 (2025)
Cluster / Pillar Cluster 1 / Pillar II Health
China Eligibility Eligible ✓ 2025 WP: no RIA restriction
Special Conditions Two-stage [Stage 2] Stage 1: 16 Sep 2025 (closed)
Verify: Open this topic on the F&T Portal →  ·  Sources: General Annexes 2026-2027, WP Part 4 (2025)
See what a full Decision Brief looks like →
Compliance traps · Scoring playbook · Consortium blueprint · 2 free examples available
This is a two-stage topic (Stage 2). Stage 1 closed 16 September 2025. Stage 2 deadline: 16 April 2026. Stage 1 page limit: 10 pages. Stage 2 page limit: 45 pages. Blind evaluation pilot applies to Stage 1.
This topic uses non-standard evaluation thresholds: Stage 2: 4 (Excellence) / 4 (Impact) / 4 (Implementation), cumulative 12. Standard thresholds are 3/3/3 cumulative 10.
US entities eligible: In recognition of the opening of the US National Institutes of Health’s programmes to European researchers, legal entities established in the United States of America are eligible to receive Union funding under this topic.
Copernicus/Galileo: If the project uses satellite-based earth observation, positioning, navigation and/or related timing data, beneficiaries must make use of Copernicus and/or Galileo/EGNOS.

Expected Outcomes

  1. Persons with intellectual disabilities and their families enjoy an improved quality of life, are empowered and have more independence through the support of innovative research.
  2. The scientific community develops innovative solutions — medical, technological, digital or others — to reverse and/or reduce the severity level of the intellectual disability as soon as possible, especially in children, improving the health and autonomy of persons with intellectual disabilities and relieving their carers.
  3. Policymakers, health and care services, patient organisations, funders, the scientific community, and other relevant bodies are informed of the research advances and best practices addressing the health and needs of persons with intellectual disabilities and help reduce the impact of those disabilities on individuals, their families and society.

Want the full analysis?

The key facts above tell you WHAT. The full Decision Brief tells you HOW to win.

Compliance traps Scoring playbook Consortium blueprint Positioning guide Red flags Quick-start checklist
Order Full Brief — €79
Delivered within 1 working day
Disclaimer: This page is produced using advanced AI analysis and reviewed by an experienced EU grant engineer. While we take care to ensure accuracy, the information may contain errors or become outdated. It is the applicant’s sole responsibility to verify all facts against the official EU Funding & Tenders Portal before making any decisions. Global Disruption accepts no liability for errors, omissions, or decisions made based on this content. No refunds are offered for Key Facts pages or Decision Briefs.